TJP1 and colitis: The oral administration of this engineered EcN to mice improved colitis-related dysfunctions such as weight loss and colon length shortening besides restoring the levels of tight junction protein ZO-1, beneficial commensals, and SCFAs in colonic tissues to normal [171].